The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 28, 2015

Filed:

Mar. 24, 2010
Applicants:

Ramakrishna Nirogi, Hyderabad, IN;

Anil Karbhari Shinde, Hyderabad, IN;

Rama Sastri Kambhampati, Hyderabad, IN;

Rajesh Kumar Badange, Hyderabad, IN;

Veena Reballi, Hyderabad, IN;

Anil Kashinath Chindhe, Hyderabad, IN;

Rambabu Namala, Hyderabad, IN;

Mohamad Sadik Abdulhamid Mulla, Hyderabad, IN;

Ishtiyaque Ahmad, Hyderabad, IN;

Renny Abraham, Hyderabad, IN;

Venkateswarlu Jasti, Hyderabad, IN;

Inventors:

Ramakrishna Nirogi, Hyderabad, IN;

Anil Karbhari Shinde, Hyderabad, IN;

Rama Sastri Kambhampati, Hyderabad, IN;

Rajesh Kumar Badange, Hyderabad, IN;

Veena Reballi, Hyderabad, IN;

Anil Kashinath Chindhe, Hyderabad, IN;

Rambabu Namala, Hyderabad, IN;

Mohamad Sadik Abdulhamid Mulla, Hyderabad, IN;

Ishtiyaque Ahmad, Hyderabad, IN;

Renny Abraham, Hyderabad, IN;

Venkateswarlu Jasti, Hyderabad, IN;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 401/12 (2006.01); A61K 31/4468 (2006.01); A61P 25/18 (2006.01); A61P 25/28 (2006.01); C07D 211/58 (2006.01); C07D 401/14 (2006.01); A61K 31/4709 (2006.01); A61K 31/4725 (2006.01);
U.S. Cl.
CPC ...
C07D 211/58 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); A61K 31/4468 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01);
Abstract

The present invention relates to novel sulfone compounds as 5-HTreceptor ligands of the formula (I), and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their derivatives, prodrugs, tautomers, stereoisomers, polymorphs, solvates, hydrates, metabolites, N-oxides, pharmaceutically acceptable salts and compositions containing them. These compounds are useful in the treatment/prevention of various disorders that are related to 5-HTreceptor functions.


Find Patent Forward Citations

Loading…